INVELTYS (loteprednol etabonate/KPI-121) Drug Insight and U.S. Market Analysis, 2023-2032: Projected to Dominate the Acute Ocular Pain (AOP) Sector
29 janv. 2024 12h51 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "United States INVELTYS Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report offers an...